Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 2 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Endometrial Hyperplasia 1

Interventions

Megestrol Acetate 7 Medroxyprogesterone Acetate 4 Progestins 3 Metformin 3 Tirzepatide 2 Progesterone 2 Letrozole 2 Biopsy 2 Atorvastatin 2 semaglutide 1 ricin A-GnRH conjugate 1 exemestane 1 estradiol, norethindrone drug combination 1 Tamoxifen 1 Rosuvastatin Calcium 1 Resistance Training 1 Pterocarpus marsupium 1 Pharmacogenomic Variants 1 Nutrition Assessment 1 Magnetic Resonance Spectroscopy 1 Levonorgestrel 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Hysteroscopy 1 Hysterectomy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Gonadotropin-Releasing Hormone 1 Genetic Testing 1 Everolimus 1 Estrogen Replacement Therapy 1 Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Hyperplasia × Levonorgestrel × Clear all

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡